RADIOFREQUENCY TECHNOLOGY: VALUE IN THE ORTHOPAEDIC OPERATING ROOM von Bilir, S.P, Munakata, J, Borgman, B, Ferrufino, C, DeKoven, M

Volltext

BUDGET IMPACT MODEL FOR SELEXIPAG: TAKING A US PAYER PERSPECTIVE von Beaudet, A, Tsang, Y, Hunsche, E, Drake, W, Bilir, S.P

Volltext

Costs Of Treating Skeletal-Related Events Among Prostate Cancer Patients With Bone Metastases In A Commercial Insured Population In The Us von Zhong, Y, Yao, J, Donga, P, Bilir, S.P, Valderrama, A

Volltext

PCN74 COST OF IMMUNOTHERAPY TO TREAT EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) von Bilir, S.P., Ogale, S.

Volltext

Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk von Li, H, Bilir, S.P, Donga, P, Samiian, A, Munakata, J

Volltext

Mathematical Simulations Of Alogliptin-Pioglitazone-Treated Patients Meeting Quality Assurance Hba1c Threshold Requirements von Bilir, S.P, Iversen, P, Bron-Green, M, Lee, W.C

Volltext

Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools: Key Implementation Considerations and Results von Wehler, E.A, Bilir, S.P, Bertwistle, D, Leyva, V, Munakata, J

Volltext

Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in the United States von Bilir, S.P, Zhao, Z, Wehler, E, Munakata, J, Barber, B

Volltext

Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and Spain von Bilir, S.P, Zhao, Z, Wehler, E.A, Munakata, J, Barber, B

Volltext

Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Vi... von Valderrama, A, Bilir, S.P, Wehler, E.A, Seal, B.S, Wen, L, Yaldo, A, Munakata, J

Volltext

PSY15 Lifetime Impact of On-Demand Treatment Options on Bleeding, Hospitalization, and QOl in Italian Hemophilia Patients With Inhibitors von Bilir, S.P, Petrilla, A.A, Trochlil, K, Weatherall, J, Lee, W.C

Volltext

PCN97 Cost-Effectiveness of Atezolizumab Monotherapy Versus Pembrolizumab Monotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer von Lin, C.W., Rosettie, K., Bilir, S.P., Celik, H., Abogunrin, S., Ogale, S.

Volltext

PCN80 BUDGET IMPACT IN THE USA OF LIPOSOMAL IRINOTECAN AS A POST-GEMCITABINE TREATMENT OPTION FOR PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA (MPC) von Herrera-Restrepo, O., Ferrufino, C., Bilir, S.P., Cockrum, P., Valderrama, A.

Volltext

PSY17 - BUDGET IMPACT MODEL FOR SELEXIPAG: TAKING A US PAYER PERSPECTIVE von Beaudet, A., Tsang, Y., Hunsche, E., Drake, W., Bilir, S.P.

Volltext

PHP10 - RADIOFREQUENCY TECHNOLOGY: VALUE IN THE ORTHOPAEDIC OPERATING ROOM von Bilir, S.P., Munakata, J., Borgman, B., Ferrufino, C., DeKoven, M.

Volltext

PCN52 - Costs Of Treating Skeletal-Related Events Among Prostate Cancer Patients With Bone Metastases In A Commercial Insured Population In The Us von Zhong, Y., Yao, J., Donga, P., Bilir, S.P., Valderrama, A.

Volltext

PDB108 - Cost Effectiveness Analysis of Flash Glucose Monitoring for Type 2 Diabetes Patients Receiving Insulin Treatment In The Uk von Li, H., Bilir, S.P., Donga, P., Samiian, A., Munakata, J.

Volltext

PDB144 - Mathematical Simulations Of Alogliptin-Pioglitazone-Treated Patients Meeting Quality Assurance Hba1c Threshold Requirements von Bilir, S.P., Iversen, P., Bron-Green, M., Lee, W.C.

Volltext

PCN79 - Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and Spain von Bilir, S.P., Zhao, Z., Wehler, E.A., Munakata, J., Barber, B.

Volltext

PRM82 - Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools: Key Implementation Considerations and Results von Wehler, E.A., Bilir, S.P., Bertwistle, D., Leyva, V., Munakata, J.

Volltext